Dishman Carbogen Amcis Ltd.
Contract research and manufacturing organisation (CRAM) producing high-potency APIs, vitamin D an…
Contract research and manufacturing organisation (CRAM) producing high-potency APIs, vitamin D analogues, and drug intermediates for global innovator pharma companies. Combines Dishman India with Swiss CRAM Carbogen Amcis.
- Type
- Manufacturer
- Location
- Ahmedabad, India
- Founded
- 1983
- Website
- dishmangroup.com
- Categories
- Medical & Healthcare Supplies, Chemicals & Plastics
- Markets
- India, Switzerland, United States, United Kingdom, Germany
Verified facts
- domain-registered (green), checked 2026-08-08 Domain registry record
- lei-active (green), checked 2026-08-23 GLEIF global LEI register (golden copy)
- export-registered (green), checked 2026-08-21 Pharmexcil member directory (Pharmaceuticals Export Promotion Council of India, Ministry of Commerce)
- registered-manufacturer (green), checked 2026-08-21 Pharmexcil member directory (Pharmaceuticals Export Promotion Council of India, Ministry of Commerce)
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
Claimed certifications
- ISO 9001, Quality Management IAF CertSearch
- Good Manufacturing Practice
- FDA Registered FDA Establishment Registration
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Chemical substances imported into the EU above 1 tonne/year must be REACH-registered. ECHA (REACH)